Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PAVmed Inc. stock logo
PAVM
PAVmed
$1.51
-13.7%
$2.73
$1.17
▼
$28.44
$13.99M0.9224,005 shs38,984 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$61.93
-4.0%
$64.77
$28.81
▼
$77.00
$206.34M0.1238,387 shs23,787 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PAVmed Inc. stock logo
PAVM
PAVmed
+7.36%+7.36%-27.39%-65.42%-81.77%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-1.80%-8.28%+10.68%-3.60%+100.93%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PAVmed Inc. stock logo
PAVM
PAVmed
$1.51
-13.7%
$2.73
$1.17
▼
$28.44
$13.99M0.9224,005 shs38,984 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$61.93
-4.0%
$64.77
$28.81
▼
$77.00
$206.34M0.1238,387 shs23,787 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PAVmed Inc. stock logo
PAVM
PAVmed
+7.36%+7.36%-27.39%-65.42%-81.77%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-1.80%-8.28%+10.68%-3.60%+100.93%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
PAVmed Inc. stock logo
PAVM
PAVmed
2.00
Hold$56.003,608.61% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2.67
Moderate Buy$80.0029.18% Upside

Current Analyst Ratings Breakdown

Latest PAVM and PDEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Boost Price TargetBuy$74.00 ➝ $80.00
11/12/2026
PAVmed Inc. stock logo
PAVM
PAVmed
Reiterated RatingSell (E+)
11/10/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B-)
11/9/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeStrong-Buy ➝ Hold
10/23/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B) ➝ Hold (C+)
10/8/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B)
9/21/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B-) ➝ Hold (C+)
9/15/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold ➝ Strong-Buy
9/11/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Boost Price TargetBuy$70.00 ➝ $74.00
9/4/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B-)
8/24/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B-) ➝ Hold (C+)
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
PAVmed Inc. stock logo
PAVM
PAVmed
$70K172.57N/AN/A($2.42) per share-0.62
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$77.55M2.56$3.75 per share16.52$15.42 per share4.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
PAVmed Inc. stock logo
PAVM
PAVmed
$400K-$9.11N/AN/AN/A-12,406.76%-61.95%-17.08%N/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$13.66M$3.6517.6718.43N/A15.12%26.18%16.69%2/4/2027 (Estimated)

Latest PAVM and PDEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q1 2027
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.92+$0.25$0.92$20.40 million$20.56 million
9/3/2026Q4 2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.87+$0.20$0.87$19.20 million$20.41 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
PAVmed Inc. stock logo
PAVM
PAVmed
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
PAVmed Inc. stock logo
PAVM
PAVmed
0.98
1.19
1.19
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.25
4.19
2.49

Institutional Ownership

CompanyInstitutional Ownership
PAVmed Inc. stock logo
PAVM
PAVmed
19.93%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%

Insider Ownership

CompanyInsider Ownership
PAVmed Inc. stock logo
PAVM
PAVmed
13.40%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
48.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
PAVmed Inc. stock logo
PAVM
PAVmed
418.00 million6.93 millionNo Data
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2063.20 million1.66 millionNot Optionable

Recent News About These Companies

Pro-Dex (NASDAQ:PDEX) Price Target Raised to $80.00
Pro-Dex (PDEX) Set to Post Earnings on Thursday
How Pro-dex Inc. (PDEX) Affects Rotational Strategy Timing
Best Momentum Stocks to Buy for September 18th
New Strong Buy Stocks for September 18th
Pro-Dex (NASDAQ:PDEX) CEO Sells 765 Shares of Stock
Pro-Dex (NASDAQ:PDEX) CFO Sells 2,300 Shares
Pro-Dex Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

PAVmed stock logo

PAVmed NASDAQ:PAVM

$1.51 -0.24 (-13.71%)
Closing price 03:57 PM Eastern
Extended Trading
$1.50 -0.01 (-0.33%)
As of 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$61.93 -2.55 (-3.95%)
Closing price 04:00 PM Eastern
Extended Trading
$62.92 +0.98 (+1.59%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.